A detailed history of Kanawha Capital Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Kanawha Capital Management LLC holds 2,052 shares of NVO stock, worth $179,857. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,052
Previous 2,148 4.47%
Holding current value
$179,857
Previous $306,000 20.26%
% of portfolio
0.02%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$119.07 - $145.42 $11,430 - $13,960
-96 Reduced 4.47%
2,052 $244,000
Q1 2024

Apr 29, 2024

BUY
$102.11 - $135.92 $219,332 - $291,956
2,148 New
2,148 $275,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Kanawha Capital Management LLC Portfolio

Follow Kanawha Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kanawha Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kanawha Capital Management LLC with notifications on news.